ERD

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral scleros...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Validation of a Lower Back “Wearable”-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Di...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Iron as a therapeutic target for Parkinson's disease

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Bioavailable Trace Metals in Neurological Diseases

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Validation of a Step Detection Algorithm during Straight Walking and Turning in Patients with Parkinson’s Disease and ...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Comparison of Internal Standard Approaches for SRM Analysis of Alpha-Synuclein in Cerebrospinal Fluid

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Report on status of posting results in the study registry

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Communication and Dissemination tools including website

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Periodic Reporting for period 5 - FAIR-PARK-II (Conservative iron chelation as a disease-modifying strategy in Parkinson...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotem...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Seven Solutions for Neuroprotection in Parkinson's Disease

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and ce...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinic...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared wi...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Poly‐ GP in cerebrospinal fluid links C9orf72 ‐associated dipeptide repeat expression to the asymptomatic phase of A...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Resources